• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vaxil Bio Ltd

+ Add to Watchlist

VAXL:IT

118.30 ILs 11.40 10.66%

As of 10:24:22 ET on 09/18/2014.

Company Profile for Vaxil Bio Ltd (VAXL)

Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.

Contact Information

Vaxil Bio Ltd

Bl 13A, 13 Einstein st.
Weizmann Science Park
Nes Ziona, 74036
Israel
Phone: 972-8-939-6948
Fax: 972-8-939-6996

Key Executives for Vaxil Bio Ltd (VAXL)

Lior CarmonFounder/CEO/Head:ResearchJulian LevyPresident/CFO
Riva KovjazinDirector:ResearchOfira MoranClinical Trials Monitoring

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil